🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 14 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/08/2013 45,95 46,57 45,89 46,25 +0,17% 1,49% 10.411.985
09/08/2013 46,22 46,55 46,05 46,17 -0,16% 1,07% 8.266.834
08/08/2013 46,43 46,60 45,98 46,25 -0,16% 1,34% 9.045.707
07/08/2013 46,14 46,52 46,14 46,33 +0,23% 0,83% 10.130.282
06/08/2013 46,26 46,36 45,89 46,22 -0,19% 1,03% 10.421.836
05/08/2013 46,17 46,43 45,87 46,31 -0,02% 1,22% 7.114.977
02/08/2013 46,22 46,32 45,97 46,32 -0,08% 0,74% 9.350.466
01/08/2013 46,22 46,45 45,84 46,36 +0,85% 1,32% 14.198.094
31/07/2013 46,28 46,50 45,77 45,96 +0,25% 1,57% 22.612.067
30/07/2013 46,08 46,83 45,65 45,85 -0,60% 2,57% 17.583.554
29/07/2013 46,06 46,56 45,94 46,13 -0,31% 1,33% 10.785.597
26/07/2013 45,85 46,27 45,59 46,27 +0,66% 1,48% 10.318.818
25/07/2013 45,35 45,98 45,18 45,96 +0,84% 1,77% 10.522.339
24/07/2013 45,73 45,84 45,33 45,58 -0,33% 1,11% 9.370.378
23/07/2013 45,62 46,01 45,36 45,73 +0,44% 1,42% 9.685.616
22/07/2013 45,66 46,04 45,37 45,53 -0,15% 1,46% 11.861.998
19/07/2013 45,30 45,73 45,04 45,60 +0,82% 1,52% 14.911.678
18/07/2013 45,83 45,93 45,18 45,23 -1,52% 1,62% 18.677.456
17/07/2013 46,07 46,54 45,93 45,93 -0,21% 1,33% 9.964.174
16/07/2013 46,34 46,59 45,83 46,02 -0,60% 1,65% 16.006.733
15/07/2013 46,29 46,65 46,05 46,30 -0,04% 1,30% 10.117.811
12/07/2013 46,18 46,43 45,98 46,32 +0,48% 0,97% 9.280.564
11/07/2013 46,21 46,28 45,93 46,10 +0,73% 0,76% 11.991.216
10/07/2013 45,44 45,97 45,41 45,76 +0,71% 1,24% 8.154.174
09/07/2013 45,53 45,80 45,43 45,44 +0,44% 0,82% 10.811.902
08/07/2013 45,20 45,45 45,08 45,24 +0,53% 0,82% 11.504.315
05/07/2013 44,78 45,13 44,48 45,00 +1,31% 1,47% 8.491.944
03/07/2013 44,35 44,59 44,05 44,42 +0,00% 1,23% 7.203.952
02/07/2013 43,98 44,59 43,92 44,42 +0,50% 1,52% 11.859.063
01/07/2013 44,14 44,70 44,10 44,20 -0,28% 1,36% 13.741.586